Number of the records: 1
agonisty muskarínové
SYS d018721 LBL 00000cz--a2200000n--4500 005 20250606214454.3 008 940601|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $a BA006 $a BA006 $d BA006 065 $a D27.505.519.625.120.140.500 065 $a D27.505.696.577.120.140.500 066 $a 01 $c 03 150 $a agonisty muskarínové $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Cholinergic Agonists, Muscarinic $2 eng 450 $w v $a agonisty muskarínové cholínergické $2 slo 550 $7 sllk_us_auth*d008916 $Y Miotics $w b $a miotiká 550 $7 sllk_us_auth*d010277 $Y Parasympathomimetics $w b $a parasympatomimetiká 665 $a 95 $2 eng 680 9-
$i Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. $2 eng 750 -2
$a Muscarinic Agonists $2 eng 980 $x M
Number of the records: 1